nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—Salbutamol—chronic obstructive pulmonary disease	0.624	1	CrCtD
Levonordefrin—Isoetarine—Salbutamol—chronic obstructive pulmonary disease	0.0762	0.211	CrCrCtD
Levonordefrin—Norepinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0711	0.197	CrCrCtD
Levonordefrin—Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.0578	0.16	CrCrCtD
Levonordefrin—Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.0578	0.16	CrCrCtD
Levonordefrin—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0538	0.149	CrCrCtD
Levonordefrin—Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.0438	0.121	CrCrCtD
Levonordefrin—Isoetarine—ADRB2—chronic obstructive pulmonary disease	0.000399	0.16	CrCbGaD
Levonordefrin—Salbutamol—ADRB2—chronic obstructive pulmonary disease	0.000308	0.123	CrCbGaD
Levonordefrin—Phenylpropanolamine—ADRB2—chronic obstructive pulmonary disease	0.000199	0.0794	CrCbGaD
Levonordefrin—Droxidopa—ADRB2—chronic obstructive pulmonary disease	0.000182	0.0729	CrCbGaD
Levonordefrin—Isoprenaline—ADRB2—chronic obstructive pulmonary disease	0.000166	0.0663	CrCbGaD
Levonordefrin—Phenylpropanolamine—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.0657	CrCbGaD
Levonordefrin—Epinephrine—TNF—chronic obstructive pulmonary disease	0.000157	0.0629	CrCbGaD
Levonordefrin—Norepinephrine—ADRB2—chronic obstructive pulmonary disease	0.000154	0.0614	CrCbGaD
Levonordefrin—Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.0569	CrCbGaD
Levonordefrin—Epinephrine—ADRB2—chronic obstructive pulmonary disease	0.000139	0.0557	CrCbGaD
Levonordefrin—Dopamine—SLC6A4—chronic obstructive pulmonary disease	0.00013	0.0518	CrCbGaD
Levonordefrin—Norepinephrine—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.0508	CrCbGaD
Levonordefrin—Dopamine—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0472	CrCbGaD
Levonordefrin—Epinephrine—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.0461	CrCbGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.6e-05	0.00207	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.55e-05	0.00203	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.52e-05	0.00201	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APIP—chronic obstructive pulmonary disease	2.52e-05	0.00201	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.49e-05	0.00199	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.48e-05	0.00198	CbGpPWpGaD
Levonordefrin—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	2.48e-05	0.00198	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.43e-05	0.00194	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.42e-05	0.00193	CbGpPWpGaD
Levonordefrin—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.41e-05	0.00192	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.4e-05	0.00192	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.39e-05	0.0019	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	2.36e-05	0.00189	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.36e-05	0.00188	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.32e-05	0.00185	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.32e-05	0.00185	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.3e-05	0.00184	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.3e-05	0.00184	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	2.3e-05	0.00183	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.27e-05	0.00181	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.26e-05	0.00181	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.23e-05	0.00178	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.23e-05	0.00178	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.2e-05	0.00176	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.18e-05	0.00174	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.17e-05	0.00173	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.15e-05	0.00171	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	2.14e-05	0.00171	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.12e-05	0.00169	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.11e-05	0.00169	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.09e-05	0.00167	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.08e-05	0.00166	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.07e-05	0.00165	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.05e-05	0.00164	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.05e-05	0.00164	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.04e-05	0.00163	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.00162	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GC—chronic obstructive pulmonary disease	2e-05	0.00159	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.97e-05	0.00157	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.96e-05	0.00156	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.95e-05	0.00156	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.94e-05	0.00155	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.93e-05	0.00154	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.9e-05	0.00152	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.9e-05	0.00151	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.00148	CbGpPWpGaD
Levonordefrin—ADRA2B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.85e-05	0.00148	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.84e-05	0.00147	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.84e-05	0.00147	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.82e-05	0.00145	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.81e-05	0.00144	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.79e-05	0.00143	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.78e-05	0.00142	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.76e-05	0.00141	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.75e-05	0.00139	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	1.74e-05	0.00139	CbGpPWpGaD
Levonordefrin—ADRA2C—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.73e-05	0.00138	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.72e-05	0.00137	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.71e-05	0.00136	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.7e-05	0.00135	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.7e-05	0.00135	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.67e-05	0.00133	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.66e-05	0.00132	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	1.62e-05	0.0013	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.59e-05	0.00127	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.58e-05	0.00126	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.00126	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.56e-05	0.00125	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.55e-05	0.00124	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.53e-05	0.00122	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.51e-05	0.0012	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.5e-05	0.0012	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.48e-05	0.00118	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.48e-05	0.00118	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.47e-05	0.00118	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.46e-05	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.45e-05	0.00116	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.44e-05	0.00115	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.43e-05	0.00114	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.41e-05	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.41e-05	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.39e-05	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.0011	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.38e-05	0.0011	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.36e-05	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.32e-05	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.31e-05	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.3e-05	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.23e-05	0.000979	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.22e-05	0.000974	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.2e-05	0.000961	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.2e-05	0.000958	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.19e-05	0.000952	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.19e-05	0.000948	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.19e-05	0.000946	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.18e-05	0.000945	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000944	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.17e-05	0.000937	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.16e-05	0.000928	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.14e-05	0.000908	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000903	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.12e-05	0.000896	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000896	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000893	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.11e-05	0.000889	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.11e-05	0.000884	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000882	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.1e-05	0.000879	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.1e-05	0.000875	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000871	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000861	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.07e-05	0.000856	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.07e-05	0.000852	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.07e-05	0.000851	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.06e-05	0.000844	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.06e-05	0.000844	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.05e-05	0.000837	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.000837	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.03e-05	0.000819	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.97e-06	0.000795	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.96e-06	0.000795	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CTGF—chronic obstructive pulmonary disease	9.85e-06	0.000786	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.74e-06	0.000777	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.59e-06	0.000765	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.59e-06	0.000765	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.33e-06	0.000744	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.17e-06	0.000732	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	9.17e-06	0.000732	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	9.13e-06	0.000729	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.07e-06	0.000724	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.05e-06	0.000722	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	8.99e-06	0.000718	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	8.98e-06	0.000716	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.91e-06	0.000711	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.87e-06	0.000708	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	8.77e-06	0.000699	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.71e-06	0.000695	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.71e-06	0.000695	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	8.59e-06	0.000685	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.52e-06	0.00068	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.52e-06	0.00068	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.39e-06	0.000669	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.21e-06	0.000655	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.15e-06	0.000651	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.09e-06	0.000645	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	8e-06	0.000638	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.79e-06	0.000622	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.67e-06	0.000612	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.64e-06	0.000609	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	7.62e-06	0.000608	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.62e-06	0.000608	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.57e-06	0.000604	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.48e-06	0.000597	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.46e-06	0.000596	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.37e-06	0.000588	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.13e-06	0.000569	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.08e-06	0.000565	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.05e-06	0.000562	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	6.99e-06	0.000558	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.95e-06	0.000555	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.71e-06	0.000535	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.59e-06	0.000526	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.58e-06	0.000525	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.35e-06	0.000506	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.3e-06	0.000503	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.24e-06	0.000498	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.23e-06	0.000497	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.19e-06	0.000494	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	6.16e-06	0.000492	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.15e-06	0.00049	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.06e-06	0.000484	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.93e-06	0.000473	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.88e-06	0.000469	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.79e-06	0.000462	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.76e-06	0.00046	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	5.76e-06	0.000459	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.75e-06	0.000459	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.72e-06	0.000457	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	5.68e-06	0.000453	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.65e-06	0.000451	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.51e-06	0.00044	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.38e-06	0.000429	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.35e-06	0.000427	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.35e-06	0.000427	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.35e-06	0.000427	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.18e-06	0.000413	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.15e-06	0.000411	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.14e-06	0.00041	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.12e-06	0.000409	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.81e-06	0.000384	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.78e-06	0.000382	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.78e-06	0.000381	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.71e-06	0.000375	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	4.67e-06	0.000373	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.67e-06	0.000373	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.5e-06	0.000359	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	4.48e-06	0.000358	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.37e-06	0.000349	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.34e-06	0.000347	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-06	0.000342	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.21e-06	0.000336	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.18e-06	0.000334	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.18e-06	0.000334	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.02e-06	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.93e-06	0.000314	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.89e-06	0.00031	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.84e-06	0.000306	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.75e-06	0.0003	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	3.64e-06	0.00029	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.58e-06	0.000286	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	3.48e-06	0.000278	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.44e-06	0.000274	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.4e-06	0.000272	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.28e-06	0.000262	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.24e-06	0.000258	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.2e-06	0.000255	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.18e-06	0.000254	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.13e-06	0.00025	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.08e-06	0.000246	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.05e-06	0.000243	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.02e-06	0.000241	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.91e-06	0.000232	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.88e-06	0.000229	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.78e-06	0.000222	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.76e-06	0.000221	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.64e-06	0.000211	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.58e-06	0.000206	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.58e-06	0.000206	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.54e-06	0.000202	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.51e-06	0.000201	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.49e-06	0.000199	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.46e-06	0.000196	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.37e-06	0.000189	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.34e-06	0.000186	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.32e-06	0.000185	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.26e-06	0.00018	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.1e-06	0.000167	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.09e-06	0.000167	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.07e-06	0.000165	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.03e-06	0.000162	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.95e-06	0.000156	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.93e-06	0.000154	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.91e-06	0.000153	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.89e-06	0.000151	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.79e-06	0.000143	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.71e-06	0.000136	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.58e-06	0.000126	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.56e-06	0.000125	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.45e-06	0.000116	CbGpPWpGaD
